Concepedia

Publication | Open Access

Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both

87

Citations

18

References

2016

Year

Abstract

isrctn.com Identifier: ISRCTN12808747.

References

YearCitations

Page 1